Tom Essaye Interviewed with Yahoo Finance on August 4, 2020
Yahoo Finance’s Brian Sozzi and Alexis Christoforous break down latest market action with The Sevens Report Founder, Tom Essaye.
Employee account created by MemberMouse
Yahoo Finance’s Brian Sozzi and Alexis Christoforous break down latest market action with The Sevens Report Founder, Tom Essaye.
Tom Essaye – Sevens Report Founder and President weighs on on current market moves with Adam Shapiro and Julie Hyman on Yahoo Finance’s On The Move.
“To be clear, from an actual policy standpoint, it’s universally expected that the Fed won’t make any…” wrote Tom Essaye, editor of the Sevens Report.
“Oil has shown resilience this week” with WTI prices just shy of multi-month highs thanks, in part, to “optimism that a COVID-19 vaccine will eventually…” said Tyler Richey, co-editor at Sevens Report Research.
Tom Essaye, founder of the Sevens Report, told Yahoo Finance on Monday that markets are downplaying key problems associated with vaccine development…
Sevens Report Research Founder Tom Essaye speaks with Yahoo Finance’s Alexis Christoforous, Brian Sozzi and Jared Blikre about the latest market moves.
Tom Essaye, editor of the Sevens Report, said Friday that even the S&P 500 has held onto its week-to-date advance in large part thanks to Microsoft, Amazon and Apple…
“A combination of stimulus, positive trends in the virus, economic reopenings and hopes for a vaccine drove stocks higher in [the second quarter],” wrote Tom Essaye, founder of The Sevens Report.
According to Tom Essaye, founder of The Sevens Report, stocks could be missing a few “key ingredients” necessary for an even more extended rally.“A combination of 1) Stimulus, 2) Positive trends in the virus, 3) Economic…” Essaye wrote.
“A combination of 1) Stimulus, 2) Positive trends in the virus, 3) Economic reopenings and 4) Hopes for a vaccine drove stocks higher in Q2…” wrote Tom Essaye, the founder of The Sevens Report.
4880 Donald Ross Rd., Suite 210
Palm Beach Gardens, FL 33418
info@sevensreport.com
(561) 408-0918